126 related articles for article (PubMed ID: 25595904)
1. A novel orally active water-soluble inhibitor of human glutathione transferase exerts a potent and selective antitumor activity against human melanoma xenografts.
De Luca A; Rotili D; Carpanese D; Lenoci A; Calderan L; Scimeca M; Mai A; Bonanno E; Rosato A; Geroni C; Quintieri L; Caccuri AM
Oncotarget; 2015 Feb; 6(6):4126-43. PubMed ID: 25595904
[TBL] [Abstract][Full Text] [Related]
2. A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib.
Graziani G; Artuso S; De Luca A; Muzi A; Rotili D; Scimeca M; Atzori MG; Ceci C; Mai A; Leonetti C; Levati L; Bonanno E; Tentori L; Caccuri AM
Biochem Pharmacol; 2015 May; 95(1):16-27. PubMed ID: 25795251
[TBL] [Abstract][Full Text] [Related]
3. The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasis.
De Luca A; Carpanese D; Rapanotti MC; Viguria TM; Forgione MA; Rotili D; Fulci C; Iorio E; Quintieri L; Chimenti S; Bianchi L; Rosato A; Caccuri AM
Oncotarget; 2017 Feb; 8(9):15520-15538. PubMed ID: 28107182
[TBL] [Abstract][Full Text] [Related]
4. Characterization of water-soluble esters of nitrobenzoxadiazole-based GSTP1-1 inhibitors for cancer treatment.
Di Paolo V; Fulci C; Rotili D; De Luca A; Tomassi S; Serra M; Scimeca M; Geroni C; Quintieri L; Caccuri AM
Biochem Pharmacol; 2020 Aug; 178():114060. PubMed ID: 32473836
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma.
Pellizzari Tregno F; Sau A; Pezzola S; Geroni C; Lapenta C; Spada M; Filomeni G; Bonanno E; Federici G; Caccuri AM
Eur J Cancer; 2009 Sep; 45(14):2606-17. PubMed ID: 19665369
[TBL] [Abstract][Full Text] [Related]
6. Effects of Glutathione Transferase-Targeting Nitrobenzoxadiazole Compounds in Relation to PD-L1 Status in Human Melanoma Cells.
Sciarretta F; Fulci C; Palumbo C; Rotili D; Tentori L; Graziani G; Caccuri AM
Chemotherapy; 2019; 64(3):138-145. PubMed ID: 31639786
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure--activity relationship of new cytotoxic agents targeting human glutathione-S-transferases.
Rotili D; De Luca A; Tarantino D; Pezzola S; Forgione M; Morozzo Della Rocca B; Falconi M; Mai A; Caccuri AM
Eur J Med Chem; 2015 Jan; 89():156-71. PubMed ID: 25462236
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterisation of a new benzamide-containing nitrobenzoxadiazole as a GSTP1-1 inhibitor endowed with high stability to metabolic hydrolysis.
Di Paolo V; Fulci C; Rotili D; Sciarretta F; Lucidi A; Morozzo Della Rocca B; De Luca A; Rosato A; Quintieri L; Caccuri AM
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1131-1139. PubMed ID: 31169043
[TBL] [Abstract][Full Text] [Related]
9. 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio) hexanol: a promising new anticancer compound.
Sha HH; Wang Z; Dong SC; Hu TM; Liu SW; Zhang JY; Wu Y; Ma R; Wu JZ; Chen D; Feng JF
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29358310
[TBL] [Abstract][Full Text] [Related]
10. The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma.
Tentori L; Dorio AS; Mazzon E; Muzi A; Sau A; Cuzzocrea S; Vernole P; Federici G; Caccuri AM; Graziani G
Eur J Cancer; 2011 May; 47(8):1219-30. PubMed ID: 21269821
[TBL] [Abstract][Full Text] [Related]
11. Proapoptotic activity of new glutathione S-transferase inhibitors.
Turella P; Cerella C; Filomeni G; Bullo A; De Maria F; Ghibelli L; Ciriolo MR; Cianfriglia M; Mattei M; Federici G; Ricci G; Caccuri AM
Cancer Res; 2005 May; 65(9):3751-61. PubMed ID: 15867371
[TBL] [Abstract][Full Text] [Related]
12. RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models.
Yang H; Higgins B; Kolinsky K; Packman K; Go Z; Iyer R; Kolis S; Zhao S; Lee R; Grippo JF; Schostack K; Simcox ME; Heimbrook D; Bollag G; Su F
Cancer Res; 2010 Jul; 70(13):5518-27. PubMed ID: 20551065
[TBL] [Abstract][Full Text] [Related]
13. Nitrobenzoxadiazole-based GSTP1-1 inhibitors containing the full peptidyl moiety of (pseudo)glutathione.
Luisi G; Mollica A; Carradori S; Lenoci A; De Luca A; Caccuri AM
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):924-30. PubMed ID: 26329912
[TBL] [Abstract][Full Text] [Related]
14. Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma.
Pasello M; Michelacci F; Scionti I; Hattinger CM; Zuntini M; Caccuri AM; Scotlandi K; Picci P; Serra M
Cancer Res; 2008 Aug; 68(16):6661-8. PubMed ID: 18701490
[TBL] [Abstract][Full Text] [Related]
15. A new nitrobenzoxadiazole-based GSTP1-1 inhibitor with a previously unheard of mechanism of action and high stability.
Fulci C; Rotili D; De Luca A; Stella L; Morozzo Della Rocca B; Forgione M; Di Paolo V; Mai A; Falconi M; Quintieri L; Caccuri AM
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):240-247. PubMed ID: 28097896
[TBL] [Abstract][Full Text] [Related]
16. Glutathione S-transferase P1-1 as a target for mesothelioma treatment.
De Luca A; Pellizzari Tregno F; Sau A; Pastore A; Palumbo C; Alama A; Cicconi R; Federici G; Caccuri AM
Cancer Sci; 2013 Feb; 104(2):223-30. PubMed ID: 23121163
[TBL] [Abstract][Full Text] [Related]
17. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells.
Wang CC; Chiang YM; Sung SC; Hsu YL; Chang JK; Kuo PL
Cancer Lett; 2008 Jan; 259(1):82-98. PubMed ID: 18023967
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol Derivatives as Glutathione Transferase Inhibitors with Favorable Selectivity and Tolerated Toxicity.
Liu Q; Liu Z; Hua W; Gou S
J Med Chem; 2021 Feb; 64(3):1701-1712. PubMed ID: 33529017
[TBL] [Abstract][Full Text] [Related]
19. Novel oxadiazole analogues derived from ethacrynic acid: design, synthesis, and structure-activity relationships in inhibiting the activity of glutathione S-transferase P1-1 and cancer cell proliferation.
Yang X; Liu G; Li H; Zhang Y; Song D; Li C; Wang R; Liu B; Liang W; Jing Y; Zhao G
J Med Chem; 2010 Feb; 53(3):1015-22. PubMed ID: 20055416
[TBL] [Abstract][Full Text] [Related]
20. 6r, a novel oxadiazole analogue of ethacrynic acid, exhibits antitumor activity both in vitro and in vivo by induction of cell apoptosis and S-phase arrest.
Zhang P; Chen JH; Dong X; Tang MT; Gao LY; Zhao GS; Yu LG; Guo XL
Biomed Pharmacother; 2013 Feb; 67(1):58-65. PubMed ID: 23201007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
